Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2026-04-17 @ 4:23 PM
Study NCT ID:
NCT01051557
Status:
COMPLETED
Last Update Posted:
2021-07-19
First Post:
2010-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
NCI-2011-01409
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None